8 things you need to know about NICE’s changes to its appraisal process

The National Institute for Health and Care Excellence (NICE) has this week published its updated guide to its health technology appraisal (HTA) process following two rounds of consultations over the last six months. The aim of these changes is to streamline and accelerate the appraisal process. This consultation process has been very low key andRead more

Appraising vaccines in the UK – what’s worth a shot?

Ever since the first vaccination at the end of the 18th century (using fluid from a cowpox blister no less), the debate about vaccines has remained highly complex and emotive. The petition in the last parliament calling for wider access to the Meningitis B vaccination in the UK is the third largest petition the parliamentaryRead more

Can pharma get the right treatment? Brexit and the pharmaceutical industry

As Brexit draws closer, sectors are coming to terms with the implications of what separation may mean. The pharmaceutical industry was not one that attracted vast attention at the start of the negotiating process, with banking and farming taking up more column inches. However, as time has progressed the press, politicians and the sector itselfRead more

The Health Top Ten: Winter Edition

As the dark mornings set in and we all return to work, WA Health looks at the top ten trends, policy developments and potential pitfalls for the health sector to look out for in the run-up to Spring. New Year, New Me At this time of year many of us give ourselves New Year’s resolutionsRead more

Sector Deal or No Deal? The Verdict on the Government’s Plan for Life Sciences

The life sciences sector is the jewel in the crown of British industry and has been for some time. It outperforms all others in terms of productivity and growth, making it the teacher’s pet of the Industrial Strategy and a beacon for how industry and government can collaborate successfully on big-ticket issues such as genomicsRead more